Loading...
Custom Services order now ship next day

Satumomab

Satumomab, also known as B72.3, is a modified mouse monoclonal antibody which could specifically bind to tumor-associated glycoprotein (TAG-72). This antibody was developed by Cytogen Corporation, which was acquired by EUSA Pharma in 2008. Satumomab is usually combined with some radioactive elements to diagnose colorectal cancer and ovarian cancer.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

For Research Use Only. Not For Clinical Use.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare